Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03052569
Title Expanded Access to RXDX-105 for Cancers With RET Alterations
Recruitment No longer available
Gender both
Phase Expanded access
Variant Requirements Yes
Sponsors Ignyta, Inc.

Advanced Solid Tumor



Age Groups: adult | child | senior
Covered Countries USA

Facility Status City State Zip Country Details
Www.Ignyta.Com San Diego California 92121 United States Details
*Shaded cells indicate that there was no data available from for the field